Telaprevir SVR Data by IL28B Status Although SVR rates varied strongly according to IL28B status, Telaprevir+SoC was much better than SoC alone in all IL28B variants in the ADVANCE (first-line) and REALIZE (second-line—scan down for table) phase-3 studies. SVR/EVR/RVR by IL28B status in ADVANCE study: images.investorshub.advfn.com/images/uploads/2011/4/5/loppjTelaprevir_ADVANCE_IL28B.png SVR by IL28B status in REALIZE study: images.investorshub.advfn.com/images/uploads/2011/4/5/olqdwTelaprevir_REALIZE_IL28B.png Source: http://finance.yahoo.com/news/Data-From-Phase-3-Studies-bw-2567396588.html?x=0&.v=1